Getting New EP Devices Approved: Evidence, Regulation, and Reimbursement

September 20, 2026 | 10:45 AM (EDT) - 11:30 AM (EDT)

Share This event

Speakers
Kevin Corriveau
Director, U.S. Health Economics & Market Access
Johnson & Johnson Medical Devices
Nassir Marrouche
Director of Heart and Vascular Institute
Tulane University School of Medicine
Maria Stewart
Vice President, Health Economics & Market Access, AF Solutions and CRM-Dx
Boston Scientific
J. Peter Weiss
Cardiac Electrophysiologist
Banner University of Arizona Medical Center Phoenix (BUMCP)
Moderator
Paul Wang
Director of the Stanford Cardiac Arrhythmia Service & Professor of Medicine and of Bioengineering
Stanford Medicine

Getting New EP Devices Approved: Evidence, Regulation, and Reimbursement

Roundtable 2
September 20, 2026 | 10:45 AM (EDT) - 11:30 AM (EDT)

A brilliant prototype does not become a successful therapy by accident. This roundtable will follow the full journey from first concept to clinical adoption. Examining the evidence, regulatory strategy, trial design, reimbursement, and commercial decisions that determine whether a new EP device reaches patients. Experts will expose the common failure points, debate what “enough evidence” really means, and define how innovators can move faster without compromising safety or credibility.